Welltok has completed its Series D round of funding totaling $37 million. The latest tranche of $12 million came from Hearst Ventures and Catholic Health Initiatives, joining Bessemer Venture Partners, Emergence Capital Partners, InterWest Partners, New Enterprise Associates (NEA), and Qualcomm Ventures which provided $25 million in October. With this latest round, Welltok’s total funding in 2014 has reached $59 million.

The new funds will be used to further accelerate the company’s growth through the launch of new products and services, as well as expansion into new market segments.

“With the capital raised in 2014, we are in a great position to deliver excellence to our existing and growing client portfolio. It also enables us to focus on building new capabilities into our groundbreaking Health Optimization Platform,” said Jeff Margolis, chairman and chief executive officer of Welltok.

“Our CafeWell Health Optimization Platform makes this possible by providing payers, providers and other population health managers with the ability to guide and incentivize consumers to achieve their optimal health,” Margolis added.